Neuroradiology: Page 214

International imaging research explores yoga benefits for cancer patients
By N. Shivapriya
The health benefits of yoga have been the focus of numerous research studies. Now, a collaborative research initiative between researchers in the U.S. and India is using multimodality imaging, including functional MRI (fMRI), PET, and SPECT, to understand the benefits of yoga for cancer patients.
June 2, 2005
2005 06 02 14 50 13 706
Racial profiling: fMRI links brain activity and black-white bias
By Shalmali Pal
A variety of factors help determine how we each feel about, and react to, people of different ethnicities. These factors are closely tied to a neurological reaction that may determine our emotional response to race -- whether we are conscious of it or not. A number of recent neuroimaging studies have investigated the connection between our brains and race processing.
May 26, 2005
2005 05 20 15 43 42 706
Brain swelling without CT hypoattenuation shouldn't rule out thrombolysis
By N. Shivapriya
For acute ischemic stroke, the CT sign of brain swelling without concomitant parenchymal hypoattenuation is no reason to exclude thrombolytic therapy based on the one-third rule, according to researchers from Seoul, South Korea.
May 25, 2005
Neuroimaging study bolsters genetic basis for feeling down
By Shalmali Pal
Even on a genetic level, people who suffer from depression may be shouldering a heavy burden. First, they are carriers of a brain anomaly that makes them prone to the disorder. Second, parts of their brain may be stuck in a neurochemical loop, thwarting the ability to regulate negative emotions. Neuroscientists used multiple imaging modalities to study this genetic connection between anatomy, function, and emotion.
May 18, 2005
IPL to sell PET brain shield
By AuntMinnie.com staff writers
Isotope Products Laboratories of Valencia, CA, has signed an agreement with Scanwell Systems of Montreal to sell that company's NeuroShield device for shielding the brain from radiation during whole-body PET studies.
May 11, 2005
Nevada Imaging Centers installs 3-tesla MRI
By AuntMinnie.com staff writers
Nevada Imaging Centers has installed a 3-tesla MRI scanner at its Spring Valley location in Las Vegas.
April 28, 2005
MRI studies make sense of multifaceted schizophrenia
By Shalmali Pal
The myth of multiple personalities aside, schizophrenia is a complex disorder. Specific diagnoses can range from paranoid schizophrenia to catatonia to undifferentiated schizophrenia. Several recent studies have applied MRI to clarify this mental illness.
April 26, 2005
GE inks drug-discovery pact with Eli Lilly
By AuntMinnie.com staff writers
Multimodality vendor GE Healthcare of Chalfont St. Giles, U.K., has signed an agreement with pharmaceutical developer Eli Lilly of Indianapolis covering research into compounds that could be developed into diagnostic and therapeutic agents for Alzheimer's disease.
April 19, 2005
BrainLab gets M. D. Anderson sale
By AuntMinnie.com staff writers
Image-guided surgery (IGS) and stereotactic radiosurgery developer BrainLab said the University of Texas M. D. Anderson Cancer Center in Houston is set to install its BrainSuite iMRI device.
April 18, 2005
MR neurography proves itself in sciatica and beyond
By Shalmali Pal
Nearly 80% of people who suffer from severe sciatica are never properly diagnosed. The problem is that there is no gold standard for finding the underlying causes of sciatic pain. In fact, most patients have to undergo surgery before a definitive diagnosis can be made. MR neurography could change all that, according to a group of California-based spinal specialists.
April 14, 2005
2005 04 08 13 13 08 706
MRS detects positive neuronal changes in ex-meth abusers
By Shalmali Pal
Methamphetamine abusers who go cold turkey may experience a healthy degree of normalization in their neuronal structure and brain function, according to a study in the Archives of General Psychiatry.
April 5, 2005
ImaRx initiates SonoLysis phase II stroke trial
By AuntMinnie.com staff writers
Pharmaceutical developer ImaRx Therapeutics said the first patient has been treated in a new phase II clinical trial evaluating the safety and effectiveness of its SonoLysis product for the treatment of acute ischemic stroke.
April 4, 2005
Previous Page
Page 214 of 238
Next Page